Drug developed using DRDO technology gets DCGI approval

Drug developed using DRDO technology gets DCGI approval

Daily Current Affairs / Drug developed using DRDO technology gets DCGI approval

Change Language English Hindi

Category : Science and Tech Published on: March 18 2023

Share on facebook

A critical drug, 'prussian blue' insoluble formulations developed on a Defence Research and Development Organisation (DRDO) technology recently received approval from the Drugs Controller General of India (DCGI).
It is one of the critical medicines listed by the World Health Organisation for radiological and nuclear emergencies.
It was developed under the Technology Development Fund (TDF).
The drug has been developed based on the technology of the Institute of Nuclear Medicine and Allied Sciences (INMAS), Delhi, a laboratory of the DRDO.
The formulations are used for the decontamination of Cesium and Thallium.
The drug will be available under the trade name of Pru-DecorpTM and PruDecorp-MG.

Recent Post's

"12th Fail" wins Best Film at 71st National Film Awards; multiple actors honoured across categories.
Read More....
Vice-Admiral Sanjay Vatsayan assumes charge as Vice Chief of the Indian Navy.
Read More....
Bihar’s draft voter list shows reduction of 65 lakh voters after intensive revision.
Read More....
Malta to host 2027 Commonwealth Youth Games with eight-sport lineup including sailing and water polo.
Read More....
Google to invest ₹51,000 crore in Asia’s largest data centre in Visakhapatnam.
Read More....
Cabinet approves ₹6,520 crore outlay for PM Kisan Sampada Yojana till 2025–26.
Read More....
Fitch cuts India’s FY26 GDP forecast to 6.3%, cites limited impact of U.S. tariffs.
Read More....
Deepak Reddy appointed CEO of Manappuram Finance to lead next growth phase.
Read More....
Mascot unveiled for Asia Rugby U-20 Championship to be held in Bihar’s Rajgir.
Read More....
Lt Gen Pushpendra Singh assumes charge as Vice Chief of Army Staff.
Read More....